Mandate

Vinge represented the sellers in the divestment of Fred Holmberg & Co AB

December 31, 2014

Vinge represented the sellers in the divestment of Fred Holmberg & Co AB to Brenntag Nordic AB. Fred Holmberg & Co AB is active within the field of distribution of chemicals, biofuels and products for NOx reduction and has an expected turnover of more than SEK 700 million for 2014. Brenntag is the world leader in chemicals distribution and the acquisition strengthens Brenntag’s presence on the Nordic market.

Vinge’s team consisted of partner Jesper Ottergren together with associate Fredrik Christiansson. In addition, specialist Mathias Lindqvist has assisted with environmental law expertise and partner Pär Remnelid, together with associate Lisa Bourghardt, have assisted with competition law expertise.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025